OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/18/2026
Back to search
Official data from USPTO
MOMENTUM PHARMA MP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
06/19/2026
Trademark type
Combined
Nice classes
35, 42
Filing date
10/25/2024
Registration date
09/23/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/23/2025
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
GB
Examiner
MCDOWELL, MATTHEW J
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of "MOMENTUM PHARMA" on two lines in stylized, green, capital lettering. To the right of the wording is a globe design featuring the continents in blue and purple and the green, capital letters "MP" joined with three green triangles to form a green arrow design superimposed on the globe.
Holders and representatives
Holders
Momentum Pharma Limited
Representatives
William C. Wright Epstein Drangel LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Personnel recruitment services; Business assistance relating to the recruitment and placement of staff; Business consulting services and business management consulting in the pharmaceuticalmedicalhealthcarelife sciences fields; Market research and business marketing consulting services in the pharmaceuticalbiotechnologymedical devicediagnostics industries
Class 42
Clinical research in the field of pharmaceuticals and medical devices; Biological research; Medical research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing scientific information relating to the developmentvalidationregulatory approval of pharmaceutical drugsbiologicsmedical devices
Publications
History of USPTO decisions and trademark events.
25 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/01/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/31/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/23/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/03/2026
FIMP
FINAL DISPOSITION PROCESSED
04/02/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/23/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/23/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/23/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/05/2025
PUBO
PUBLISHED FOR OPPOSITION
08/05/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/30/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/25/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/19/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/19/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/19/2025
RFNT
REFUSAL PROCESSED BY IB
06/13/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/23/2025
RFRR
REFUSAL PROCESSED BY MPU
05/23/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/27/2025
CNRT
NON-FINAL ACTION WRITTEN
03/26/2025
DOCK
ASSIGNED TO EXAMINER
03/26/2025
MAFR
APPLICATION FILING RECEIPT MAILED
01/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/02/2025
Continuous trademark protection
Get notified about every new filing that threatens MOMENTUM PHARMA MP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.